您的购物车当前为空
CMI-392 is a dual 5-lipoxygenase inhibitor and platelet-activating factor (PAF) receptor antagonist (IC50s: 100 and 10 nM).

CMI-392 is a dual 5-lipoxygenase inhibitor and platelet-activating factor (PAF) receptor antagonist (IC50s: 100 and 10 nM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 15,000 | 8-10周 | |
| 50 mg | ¥ 19,800 | 8-10周 | |
| 100 mg | ¥ 25,500 | 8-10周 |
CMI-392 相关产品
| 产品描述 | CMI-392 is a dual 5-lipoxygenase inhibitor and platelet-activating factor (PAF) receptor antagonist (IC50s: 100 and 10 nM). |
| 靶点活性 | PAF:10 nM, 5-LOX:100 nM |
| 体内活性 | In the acute and chronic TPA models, topical treatment with CMI-392 results in a significant decrease of ear weight, inflammatory cell infiltration, and histological examination. The ED50 for PAF-induced mouse hemoconcentration and arachidonic acid-induced mouse ear edema are 2.2 and 1.8 mg/kg, respectively. |
| 分子量 | 633.15 |
| 分子式 | C31H37ClN2O8S |
| CAS No. | 205654-37-1 |
| 密度 | 1.35 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容